NCT03907306

Brief Summary

This is single-center, prospective, randomized study

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 8, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

April 8, 2019

Status Verified

April 1, 2019

Enrollment Period

1.3 years

First QC Date

March 22, 2019

Last Update Submit

April 4, 2019

Conditions

Keywords

Cold argon plasmahemorrhoidectomywound healinghemorrhoids

Outcome Measures

Primary Outcomes (1)

  • Wound healing

    Total wound healing will be assessed with the help of cytological and macroscopic methods.In the cytological method the presence of fibroblasts, mature epithelial cells, scar tissue formation and the absence of inflammation will be the criterion of wound healing, as well as the presence of macroscopic features of wound epithelialization.

    30 days

Secondary Outcomes (3)

  • Pain Intensity Measure

    2, 3, 4, 5, 6, 7, 8, 14, 21, 30 days

  • Life quality

    before operation, 8 days, 30 days

  • Microbiological contamination of wound area

    2, 8, 14, 21, 30 days

Study Arms (2)

Patients after open hemorrhoidectomy (study group)

EXPERIMENTAL

Patients to whom during a post-operation period cold argon plasma and a standard treatment will be treated. Cold argon plasma will be applied during 4 minutes at one session on the 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 14th, 21nd, 30th day after operation. The usage of antibacterial and wound healing ointments daily.

Procedure: Wound healing

Patients after open hemorrhoidectomy (control group)

ACTIVE COMPARATOR

Patients who during a post-operation period will be treated with a standard treatment.The usage of antibacterial and wound healing ointments daily.

Procedure: Wound healing

Interventions

Wound healingPROCEDURE

The measurement of a wound area is committed on the 2nd, 8th, 14th, 21nd and 30th day after operation. By means of the mathematical formulas the wound healing speed will be defined. The wound process will be researched with the help of cytological method. The wound prints will be taken on the 2nd, 8th, 14th, 21nd and 30th day after operation. Microbiological research of a wound will be held on the 2nd, 8th, 14th, 21nd and 30th day after operation (in study groups before and after the usage of CAP, in control groups once). The pain assessment will be measured by a visual analogue scale on the 2nd, 3rd,4th, 5th, 6th, 7th, 8th, 14th, 21nd and 30th day after operation. The life quality will be researched by means of Health Status Survey on the 8th and 30th day before operation.

Patients after open hemorrhoidectomy (control group)Patients after open hemorrhoidectomy (study group)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stage hemorrhoids
  • hemorrhoids

You may not qualify if:

  • patients underwent anal canals intervention
  • acute hemorrhoids
  • inflammatory bowel disease
  • co-morbidity diseases of anal canal and perianal area
  • concurrent conditions in the stage of decompensation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

State Scientific Centre of Coloproctology

Moscow, 123423, Russia

RECRUITING

MeSH Terms

Conditions

Hemorrhoids

Interventions

Wound Healing

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

RegenerationBiological Phenomena

Central Study Contacts

Nikita V. Tuktagulov

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2019

First Posted

April 8, 2019

Study Start

September 1, 2018

Primary Completion

December 31, 2019

Study Completion

March 31, 2021

Last Updated

April 8, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations